Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
about
Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI.Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.Post-treatment levels of α-fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C.Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b.JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection.Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.Interferon-α/β for treatment of chronic hepatitis C infection in the era of direct-acting antiviral agents.Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study.Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma.
P2860
Q30422395-699CE1F6-FB47-4D6A-818C-439E0527D413Q37424371-8B1F4DDF-9298-460F-983E-E10BB376CA41Q40446411-231825B3-D2E4-4348-8D1E-F2E347D0A59BQ40557601-7454038E-40C1-424E-B8D5-0EE40DF99D83Q40771120-B1629FE5-2C27-4CA0-9695-356DA9660F3BQ40791531-3CE6B287-DC01-4853-B481-057EBF95FDD0Q40826218-44165348-C74C-4DCF-8E95-34BB6BBD76EBQ41161023-FA5156E2-4ECB-4061-B063-7ABF0F2ABA47Q42208374-367FC611-2A22-4E75-A12A-4A69BC95BF89Q42249679-5B2C063D-D4D4-4593-8A96-78AFE1CBDC17Q50481283-AF1CA0C1-5E93-40E5-83BA-2401300F00F9Q53209421-C0239A74-513B-4D35-AE36-16BEB1317E88
P2860
Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inhibition of hepatocellular c ...... multicenter cooperative study.
@ast
Inhibition of hepatocellular c ...... multicenter cooperative study.
@en
type
label
Inhibition of hepatocellular c ...... multicenter cooperative study.
@ast
Inhibition of hepatocellular c ...... multicenter cooperative study.
@en
prefLabel
Inhibition of hepatocellular c ...... multicenter cooperative study.
@ast
Inhibition of hepatocellular c ...... multicenter cooperative study.
@en
P2093
P2860
P1476
Inhibition of hepatocellular c ...... multicenter cooperative study.
@en
P2093
Eiji Kajiwara
Eiji Tanaka
Gotaro Yamada
Hiromitsu Kumada
Hiroshi Adachi
Hiroshi Yatsuhashi
Hisataka Moriwaki
Joji Toyoda
Kazuaki Chayama
Kazuya Kariyama
P2860
P304
P356
10.1007/S00535-012-0641-9
P577
2012-08-09T00:00:00Z